Image

Europe Laxative Market – Industry Trends and Forecast to 2031

Pharmaceutical

Image

Europe Laxative Market – Industry Trends and Forecast to 2031

  • Pharmaceutical
  • Upcoming Report
  • Feb 2024
  • Europe
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Europe Laxative Market – Industry Trends and Forecast to 2031

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2023–2031
Diagram Market Size (Base Year) USD 1,621.87 USD Million
Diagram Market Size (Forecast Year) USD 2,522.41 USD Million
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Europe Laxative Market, By Type (Osmotic laxatives, Stimulant laxatives, Bulk laxatives, Lubricant and Emollient laxatives), Flavors (With Flavor, Without Flavor), Source (Natural, Synthetic, Others), Indication (Chronic Constipation, irritable bowel Syndrome with Constipation, Opioid-Induced constipation, Acute constipation, Others), Mode of Purchase (Prescription, Over-the-Counter), Dosage Form (Tablets, Capsules, Powder, Liquid and Gels, Suppositories, Others), Route of Administration (Oral, Rectal), Population Type (Children, Adults), Sales Channel (Hospitals, Elderly Care Centers, Home Healthcare, Pharmacy Stores, Grocer/Health and Beauty Stores, Others), Distribution Channel (Direct Sales, Wholesalers, Others) – Industry Trends and Forecast to 2031.

Europe Laxative Market

 

Europe Laxative Market Analysis and Size

The key factors driving the laxative market are the rising incidence of digestive disorders, including constipation, irritable bowel syndrome (IBS), and chronic constipation, rising Changing Dietary Habits, and increasing awareness. Europe has an aging population, and older individuals are more prone to constipation and related digestive issues. This demographic shift has fueled the demand for laxatives, as seniors seek relief from constipation symptoms. This has driven the demand for laxatives. Digestive issues can be caused by various factors, including dietary choices and sedentary lifestyles. Therefore, the increased prevalence of constipation and acclimatization of a sedentary lifestyle are the major drivers that propelled the demand of the market in the forecast period.

Data Bridge Market Research analyses that the Europe Laxative market which was USD 1,621.87 million in 2023, is likely to reach USD 2,522.41 million by 2031, and is expected to undergo a CAGR of 5.81% during the forecast period. “Hospital” dominates the sales channel segment of the market due to the growing demand for products that provide medical, nursing, and other health-related OTC services to patients. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2024 to 2031

Base Year

2023

Historic Years

2022 (Customizable to 2016-2021)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Type (Osmotic laxatives, Stimulant laxatives, Bulk laxatives, Lubricant and Emollient laxatives), Flavors (With Flavor, Without Flavor), Source (Natural, Synthetic, Others), Indication (Chronic Constipation, irritable bowel Syndrome with Constipation, Opioid-Induced constipation, Acute constipation, Others), Mode of Purchase (Prescription, Over-the-Counter), Dosage Form (Tablets, Capsules, Powder, Liquid and Gels, Suppositories, Others), Route of Administration (Oral, Rectal), Population Type (Children, Adults), Sales Channel (Hospitals, Elderly Care Centers, Home Healthcare, Pharmacy Stores, Grocer/Health and Beauty Stores, Others), Distribution Channel (Direct Sales, Wholesalers, Others)

Countries Covered

Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey, Rest of Europe

Market Players Covered

F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Ireland), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), AstraZeneca (U.K.), Johnson & Johnson Services, Inc. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Dr. Reddy's Laboratories Ltd. (India), Lupin (India), Fresenius Kabi AG (Germany), Aurobindo Pharma (India), Cipla Inc. (U.S.), Bausch Health Companies Inc. (Canada), Amneal Pharmaceuticals LLC. (U.S.), Apotex Inc. (Canada), Eli Lilly and Company (U.S.)

Market Opportunities

  • Increasing healthcare infrastructure
  • Increasing research and development activities

Market Definition

Laxatives are a type of medicated drugs, which relieve acute, and constipation and irritable bowel syndrome, by loosening the faeces and bowel movement. The laxatives are also implemented prior to before bowel procedures. The laxatives are available as over the counter (OTC), which means the laxative scan be purchased without a prescription of the doctor.

Europe Laxative Market Dynamics

Drivers

  • Rising geriatric population

The geriatric population has a significant impact on the laxative market due to the increased prevalence of constipation and gastrointestinal issues in this age group. Constipation is more common among the elderly, with various factors, such as reduced mobility, medication use, and age-related changes in bowel function, contributing to this issue. As a result, the geriatric population has a higher demand for laxative products, which can drive the market.

  • Increasing healthcare infrastructure

An enhanced healthcare infrastructure often leads to better diagnostic capabilities and increased awareness of gastrointestinal conditions, including constipation. This can result in more individuals seeking medical attention for these issues, potentially increasing the demand for laxatives.

Moreover, the growing healthcare infrastructure may incorporate telemedicine and telehealth solutions, making it easier for individuals to access medical advice and treatment recommendations for digestive health concerns. This can lead to more informed use of laxatives leading to boost the market.

Opportunities

  • Increasing Research and Development Activities

The introduction of new laxative products can diversify the product portfolio available in the market. This can provide consumers with a wider range of options, including products that may better suit their preferences and needs. Increased R&D activities can lead to the development of innovative laxative products. Researchers may explore novel formulations, delivery methods, and mechanisms of action to create more effective and tolerable laxatives. This, in turn, will extend profitable opportunities for the market.

Restraints/Challenges

  • Rising prevalence of eating disorders

Individuals with eating disorders, especially bulimia nervosa, may misuse or abuse laxatives as a means of purging after binge-eating episodes. This misuse is not a legitimate medical indication but rather a harmful behavior associated with the disorders. The misuse of laxatives among individuals with eating disorders can lead to a range of health risks, including electrolyte imbalances, dehydration, and gastrointestinal damage. The severity of these risks depends on the extent of laxative abuse. This can be a challenge for the market.

  • High cost

Developing new drugs, whether they are laxatives or other pharmaceuticals, is expensive due to the need for extensive research, clinical trials, and regulatory compliance. These high development costs can lead to a need for higher prices to recoup investments which is expected to hamper the growth of the laxative market.

  • Lack of skilled professionals

The shortage of skilled professionals may lead to delays in the diagnosis and treatment of gastrointestinal disorders that require laxatives. Patients might experience symptoms for longer periods before receiving appropriate medical attention. Skilled professionals are responsible for developing comprehensive treatment plans for patients with gastrointestinal issues which may act as challenge for the growth of the laxative market.

This laxative market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the laxative market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In March 2021, Purdue Pharma L.P. announced the launch of two Senokot Dietary Supplement Products namely Senokot Laxative Gummies – Blueberry Pomegranate flavor and Senokot Laxative Tea. Senokot Dietary Supplement Laxative Gummies - Blueberry Pomegranate Flavor is a new flavor of Senokot Laxative Gummies for gentle overnight constipation treatment. These products will be further expands the product portfolio of the company

Europe Laxative Market Scope

The laxative market is segmented on the type, flavours, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Osmotic Laxatives
    • Osmotic Laxatives With Electrolytes
      • Golytely
      • Colyte
      • Others
    • Osmotic Laxatives Without Electrolytes
      • Magnesium Hydroxide Solution
      • Epsom Salts
      • Lactulose
      • Others
  • Stimulant Laxatives
    • Bisacodyl
    • Castor Oil
    • Senna
    • Phenolphthalein
    • Others
  • Bulk Laxatives
    • Psyllium
    • Methyl Cellulose
    • Polycarbophil
    • Others
  • Lubricant and Emollient Laxatives
    • Mineral Oil
    • Glycerin Suppositories
    • Others

Flavors

  • With Flavor
    • Fruit
    • Herbal
    • Others
  • Without Flavor

Source

  • Natural
    • Psyllium
    • Rhubarb
    • Senna and Slippery Elm
  • Synthetic
    • Phenolphthalein
    • Bisacodyl
    • Picosulfate
    • Oxyphenisatin
  • Others

Indication

  • Chronic Constipation
  • Irritable Bowel Syndrome with Constipation
  • Opioid-Induced Constipation
  • Acute Constipation
  • Others.

Mode of Purchase

  • Prescription
  • Over-the-Counter

Dosage Form

  • Tablets
  • Capsules
  • Powder
  • Liquid
  • Gels
  • Suppositories
  • Others

Route of Administration

  • Oral
  • Rectal

Population Type

  • Children
  • Adults

Sales Channel

  • Hospitals
  • Elderly Care Centers
  • Home Healthcare
  • Pharmacy Stores
  • Grocer/Health and Beauty Stores
  • Others

Distribution Channel

  • Direct Sales
  • Wholesalers
  • Others

Europe Laxative Market Regional Analysis/Insights

The laxative market is analyzed and market size insights and trends are provided by country, type, flavours, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel as referenced above.

The countries covered in the market report are Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey and rest of Europe.

Germany is expected to dominate as well as expected to grow with the highest market share in the market due to increased demand of OTC products as well as wide access to products as per patients need in the country.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The laxative market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for laxative market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the Europe Laxative market. The data is available for historic period 2010-2020.

Competitive Landscape and Europe Laxative market Share Analysis

The laxative market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to laxative market.

Some of the major players operating in the laxative Market are:

  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (U.S.)
  • Teva Pharmaceutical Industries Ltd. (Ireland)
  • Sanofi (France)
  • Pfizer Inc. (U.S.)
  • GSK plc (U.K.)
  • Novartis AG (Switzerland)
  • Merck & Co., Inc. (U.S.)
  • AstraZeneca (U.K.)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Hikma Pharmaceuticals PLC (U.K.)
  • Dr. Reddy's Laboratories Ltd. (India)
  • Lupin (India)
  • Fresenius Kabi AG (Germany)
  • Aurobindo Pharma (India)
  • Cipla Inc. (U.S.)
  • Bausch Health Companies Inc. (Canada)
  • Amneal Pharmaceuticals LLC. (U.S.)
  • Apotex Inc. (Canada)
  • Eli Lilly and Company (U.S.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

The Rising geriatric population and Increasing healthcare infrastructure are the growth drivers of the Europe Laxative Market.
The Europe Laxative Market growth rate is 5.81% during the forecast period.
The Europe Laxative Market size will be worth USD 2,522.41 million by 2031 during the forecast period.
The type, flavours, source, indication, mode of purchase, dosage form, route of administration, population type, sales channel and distribution channel are the factors on which the Europe Laxative Market research is based.
The major companies in the Europe Laxative Market are F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Ireland), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Merck & Co., Inc. (U.S.), AstraZeneca (U.K.), Johnson & Johnson Services, Inc. (U.S.), Hikma Pharmaceuticals PLC (U.K.), Dr. Reddy's Laboratories Ltd. (India), Lupin (India), Fresenius Kabi AG (Germany), Aurobindo Pharma (India), Cipla Inc. (U.S.), Bausch Health Companies Inc. (Canada), Amneal Pharmaceuticals LLC. (U.S.), Apotex Inc. (Canada), Eli Lilly and Company (U.S.).
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials